Virus associated hemaphagocytic syndrome (VAHS)

Specialty: Hematology

Recommendations:

IVIG is not recommended for routine use in the treatment of VAHS. IVIG may be considered among the options for treatment of severe life threatening VAHS.

Dose:

No recommended dose or duration listed; however, expert panel recommends up to 2 g/kg divided over 2 to 5 consecutive days.